Technical Trend Evolution and Price Momentum
The stock closed at ₹113.00 on 12 Aug 2026, marking a 3.01% increase from the previous close of ₹109.70. Intraday, it traded between ₹109.65 and ₹114.00, reflecting healthy volatility. Over the past week and month, Themis Medicare’s returns have lagged the Sensex, with weekly and monthly returns at -2.25% and -3.42% respectively, compared to Sensex’s -0.35% and +0.75%. However, year-to-date and one-year returns tell a more encouraging story, with Themis Medicare outperforming the benchmark by 12.27% and 4.82% against Sensex’s -8.29% and -3.04%. This divergence suggests that while short-term momentum has been subdued, the stock’s medium-term trajectory remains positive.
MACD Signals Confirm Bullish Momentum
The Moving Average Convergence Divergence (MACD) indicator provides a clear bullish signal on the weekly chart, with the MACD line positioned above the signal line, indicating upward momentum. On the monthly timeframe, the MACD remains mildly bullish, suggesting that the longer-term trend is gradually strengthening but has yet to reach full bullish conviction. This alignment of weekly and monthly MACD readings supports the recent upgrade in technical trend from mildly bullish to bullish.
Moving Averages and KST Reinforce Uptrend
Daily moving averages have turned bullish, with the stock price comfortably above its short-term and medium-term averages. This confirms that recent buying interest is strong and sustained. The Know Sure Thing (KST) indicator, which aggregates multiple rate-of-change measures, also signals bullish momentum on the weekly chart and mildly bullish on the monthly chart. This dual timeframe confirmation adds weight to the positive technical outlook, suggesting that momentum is building across different time horizons.
Strong fundamentals, steady climb upward! This Large Cap from Telecommunication sector earned its Reliable Performer badge through consistent execution. Safety meets solid returns here!
- - Reliable Performer certified
- - Consistent execution proven
- - Large Cap safety pick
RSI and Bollinger Bands Present Mixed Signals
The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no definitive signal, hovering in neutral territory. This suggests that the stock is neither overbought nor oversold, providing room for further price appreciation without immediate risk of a reversal due to exhaustion. Conversely, Bollinger Bands indicate a bullish stance on the weekly timeframe but mildly bearish on the monthly. The weekly bullishness reflects recent price strength and volatility expansion, while the monthly mild bearishness may hint at some longer-term consolidation or resistance near the upper band.
On-Balance Volume and Dow Theory Insights
On-Balance Volume (OBV) analysis reveals no clear trend on the weekly chart but a bullish trend on the monthly chart. This divergence implies that while short-term volume flows are inconclusive, longer-term accumulation is underway, supporting the bullish technical upgrade. Dow Theory, however, shows no established trend on either weekly or monthly charts, indicating that broader market confirmation of the stock’s trend is still pending.
Valuation and Market Capitalisation Context
Themis Medicare is classified as a micro-cap stock within the Pharmaceuticals & Biotechnology sector, with a Mojo Score of 60.0 and a current Mojo Grade upgraded to Hold from Sell as of 30 Jun 2026. This upgrade reflects improved technical and fundamental conditions, signalling a more balanced risk-reward profile. Despite its micro-cap status, the stock’s recent price momentum and technical indicators suggest growing investor interest and potential for further gains.
Long-Term Performance Relative to Sensex
Examining longer-term returns, Themis Medicare has underperformed the Sensex over three and five years, with returns of -31.60% and +20.48% respectively, compared to Sensex’s +19.64% and +43.33%. However, over a decade, the stock has delivered a robust 106.17% return, albeit below the Sensex’s 180.53%. This mixed performance underscores the stock’s cyclical nature and the importance of technical momentum shifts as potential catalysts for renewed investor confidence.
Why settle for Themis Medicare Ltd? SwitchER evaluates this Pharmaceuticals & Biotechnology micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Investor Takeaway and Outlook
The technical upgrade to a bullish trend for Themis Medicare Ltd is supported by multiple indicators, notably the weekly MACD, daily moving averages, and KST readings. While some indicators such as RSI and Bollinger Bands present mixed or neutral signals, the overall momentum appears to be building. Investors should consider the stock’s micro-cap status and historical volatility, balancing the recent positive technical developments against longer-term performance challenges.
Given the stock’s outperformance relative to the Sensex year-to-date and over the past year, alongside the technical improvements, Themis Medicare may attract renewed interest from momentum-focused investors. However, the absence of a clear Dow Theory trend and mixed volume signals suggest caution and the need for confirmation through sustained price and volume strength.
In summary, Themis Medicare Ltd’s technical landscape has shifted favourably, signalling a potential phase of upward price movement. Market participants should monitor key support levels near ₹110 and resistance approaching the 52-week high of ₹147.99, while keeping an eye on evolving technical indicators for confirmation of trend durability.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
